From San Francisco, at the American Society of Hematology’s 42nd annual meeting.
Two therapies may improve survival chances of people with a bone marrow cancer called multiple myeloma. At the least, they could delay the day when patients need to undergo a bone marrow transplant, a harsh procedure that carries lethal risks, say researchers.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.